In Pharma-Factory, six different Plant Molecular Farming platforms including whole plants, algae, hairy roots and plant cell culture will be developed by SMEs working alongside academic partners. These developments will lead to shortened production cycles and increased product yields, and ultimately lower product cost to the end-users.

Plant Molecular Farming platforms provide unique opportunities as a result of specific features of the expression systems

The global market for bioengineered protein drugs was $172.5 billion in 2016 and it is expected to reach $228.4 billion by 2021.




View more details about the technology here ︎





                 
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 774078.


Pharma Factory copyright 2018